1.IL-23 P19 Expression Induced by IL-17 and IL-1beta in Rheumatoid Arthritis Synovial Mononuclear Cells.
Mi La CHO ; Yu Jung HEO ; Hye Jwa OH ; Chang Min KANG ; Seon Yeong LEE ; Yeon Sik HONG ; Ho Youn KIM
Immune Network 2008;8(1):29-37
Interleukin-23 (IL-23) is a novel pro-inflammatory cytokine which has been implicated to play a pathogenic role in rheumatoid arthritis (RA). This study was undertaken to investigate the IL-23 inductive activity of the proinflammatory cytokine IL-17, IL-1 beta and tumor necrosis factor (TNF-alpha) in RA synovial fluid mononuclear cells (SFMC). Expression of IL-23p19, IL-17, IL-1 beta and TNF-alpha in joint was examined by immunohistochemistry (IHC) of patients with RA and osteoarthritis (OA). The effects of IL-17 and IL-1 beta on expression of IL-23p19 in human SFMC from RA patients were determined by reverse transcriptase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). IL-23p19 was expressed in the RA fibroblast like synoviocyte (FLS), but not from OA FLS. Similar to the protein expression, IL-23p19 mRNA could be detected by RT-PCR in RA SFMC. IL-17 and IL-1 beta could induce RA SFMC to produce the IL-23p19. The effects of IL-17 were much stronger than IL-1 beta or TNF-alpha. These responses were observed in a dose- responsive manner. In addition, IL-17 or IL-1 beta neutralizing antibody down-regulated the expression of IL-23p19 induced by LPS in RA-SFMC. Our results demonstrate that IL-23p19 is overexpressed in RA synovium and IL-17 and IL-1 beta appears to upregulate the expression of IL-23p19 in RA-SFMC.
Antibodies, Neutralizing
;
Arthritis, Rheumatoid
;
Enzyme-Linked Immunosorbent Assay
;
Fibroblasts
;
Humans
;
Immunohistochemistry
;
Interleukin-17
;
Interleukin-1beta
;
Interleukin-23
;
Interleukin-23 Subunit p19
;
Joints
;
Osteoarthritis
;
RNA, Messenger
;
RNA-Directed DNA Polymerase
;
Synovial Fluid
;
Synovial Membrane
;
Tumor Necrosis Factor-alpha
2.IL-23 P19 Expression Induced by IL-17 and IL-1beta in Rheumatoid Arthritis Synovial Mononuclear Cells.
Mi La CHO ; Yu Jung HEO ; Hye Jwa OH ; Chang Min KANG ; Seon Yeong LEE ; Yeon Sik HONG ; Ho Youn KIM
Immune Network 2008;8(1):29-37
Interleukin-23 (IL-23) is a novel pro-inflammatory cytokine which has been implicated to play a pathogenic role in rheumatoid arthritis (RA). This study was undertaken to investigate the IL-23 inductive activity of the proinflammatory cytokine IL-17, IL-1 beta and tumor necrosis factor (TNF-alpha) in RA synovial fluid mononuclear cells (SFMC). Expression of IL-23p19, IL-17, IL-1 beta and TNF-alpha in joint was examined by immunohistochemistry (IHC) of patients with RA and osteoarthritis (OA). The effects of IL-17 and IL-1 beta on expression of IL-23p19 in human SFMC from RA patients were determined by reverse transcriptase chain reaction (RT-PCR) and enzyme-linked immunosorbent assay (ELISA). IL-23p19 was expressed in the RA fibroblast like synoviocyte (FLS), but not from OA FLS. Similar to the protein expression, IL-23p19 mRNA could be detected by RT-PCR in RA SFMC. IL-17 and IL-1 beta could induce RA SFMC to produce the IL-23p19. The effects of IL-17 were much stronger than IL-1 beta or TNF-alpha. These responses were observed in a dose- responsive manner. In addition, IL-17 or IL-1 beta neutralizing antibody down-regulated the expression of IL-23p19 induced by LPS in RA-SFMC. Our results demonstrate that IL-23p19 is overexpressed in RA synovium and IL-17 and IL-1 beta appears to upregulate the expression of IL-23p19 in RA-SFMC.
Antibodies, Neutralizing
;
Arthritis, Rheumatoid
;
Enzyme-Linked Immunosorbent Assay
;
Fibroblasts
;
Humans
;
Immunohistochemistry
;
Interleukin-17
;
Interleukin-1beta
;
Interleukin-23
;
Interleukin-23 Subunit p19
;
Joints
;
Osteoarthritis
;
RNA, Messenger
;
RNA-Directed DNA Polymerase
;
Synovial Fluid
;
Synovial Membrane
;
Tumor Necrosis Factor-alpha
3.A Case of Hemocholecystitis in a Patient with Microscopic Polyangiitis.
Ji Suk HAN ; Sung Yeon LEE ; Hyung Jik KIM ; Young Rim SONG ; Jwa Kyung KIM ; Eun Yeong HONG ; Soo Ki MIN
Korean Journal of Medicine 2012;83(1):127-131
Microscopic polyangiitis (MPA) is a systemic necrotizing vasculitis, primarily associated with rapidly progressive glomerulonephritis and alveolar hemorrhage. Approximately 50% of MPA cases are associated with gastrointestinal involvement, but rarely do cases involve the gall bladder. We report an unusual case of MPA complicated by hemocholecystitis. A 62-year-old woman was admitted to our hospital with rapidly progressive renal dysfunction and pneumonia unresponsive to antibiotics. A chest CT scan showed bilateral diffuse alveolar consolidation, and perinuclear anti-neutrophil cytoplasmic antibody (p-ANCA) staining was positive. During the course of hospitalization, the patient complained of severe abdominal pain, and an abdominal CT scan revealed acalculous cholecystitis with hemorrhage. Cholecystectomy was performed, and a gall bladder biopsy revealed fibrinoid necrosis of small arteries without granuloma. Cholecystitis should be considered in patients with unexplained upper abdominal pain and MPA.
Abdominal Pain
;
Acalculous Cholecystitis
;
Anti-Bacterial Agents
;
Antibodies, Antineutrophil Cytoplasmic
;
Arteries
;
Biopsy
;
Cholecystectomy
;
Cholecystitis
;
Female
;
Glomerulonephritis
;
Granuloma
;
Hemorrhage
;
Hospitalization
;
Humans
;
Microscopic Polyangiitis
;
Middle Aged
;
Necrosis
;
Pneumonia
;
Thorax
;
Urinary Bladder
;
Vasculitis
4.Measurement of Interleukin-33 (IL-33) and IL-33 Receptors (sST2 and ST2L) in Patients with Rheumatoid Arthritis.
Yeon Sik HONG ; Su Jin MOON ; Young Bin JOO ; Chan Hong JEON ; Mi La CHO ; Ji Hyeon JU ; Hye Jwa OH ; Yu Jung HEO ; Sung Hwan PARK ; Ho Youn KIM ; Jun Ki MIN
Journal of Korean Medical Science 2011;26(9):1132-1139
The interleukin-33 (IL-33)/ST2 pathway has emerged as an intercellular signaling system that participates in antigen-allergen response, autoimmunity and fibrosis. It has been suggested that IL-33/ST2 signaling has been involved in the pathogenesis of rheumatoid arthritis (RA), because IL-33 and its receptor have been specifically mapped to RA synovium. The aim of this study was to determine the levels of IL-33 and sST2 in sera and synovial fluids in patients with RA. The serum level of IL-33 was significantly higher in patients with RA (294.9 +/- 464.0 pg/mL) than in healthy controls (96.0 +/- 236.9 pg/mL, P = 0.002). The synovial fluid level of IL-33 was significantly higher in RA patients than in osteoarthritis patients. The level of serum sST2 was higher in RA patients than in healthy controls (P = 0.042). A significant relationship was found between the levels of IL-33 and IL-1beta (r = 0.311, P = 0.005), and IL-33 and IL-6 (r = 0.264, P = 0.017) in 81 RA patients. The levels of IL-33, sST2 and C-reactive protein decreased after conventional disease-modifying antirheumatic drugs treatment in 10 patients with treatment-naive RA. Conclusively, IL-33 is involved in the pathogenesis of RA and may reflect the degree of inflammation in patients with RA.
Adult
;
Aged
;
Antirheumatic Agents/therapeutic use
;
Arthritis, Rheumatoid/blood/drug therapy/*pathology
;
C-Reactive Protein/analysis
;
Female
;
Humans
;
Interleukin-1beta/analysis/blood
;
Interleukin-6/analysis/blood
;
Interleukins/*analysis/blood
;
Male
;
Middle Aged
;
Osteoarthritis/blood/pathology
;
Receptors, Cell Surface/*analysis/blood
;
Synovial Fluid/metabolism
5.Prognostic value of 18F-fluorodeoxyglucose positron emission tomography, computed tomography and magnetic resonance imaging in oral cavity squamous cell carcinoma with pathologically positive neck lymph node.
Eunjin JWA ; Sang Wook LEE ; Jae Seung KIM ; Jin Hong PARK ; Su Ssan KIM ; Young Seok KIM ; Sang Min YOON ; Si Yeol SONG ; Jong Hoon KIM ; Eun Kyung CHOI ; Seung Do AHN
Radiation Oncology Journal 2012;30(4):173-181
PURPOSE: To evaluate the prognostic value of preoperative neck lymph node (LN) assessment with 18F-fluorodeoxyglucose positron emission tomography (18F-FDG PET), computed tomography (CT), and magnetic resonance imaging (MRI) in oral cavity squamous cell carcinoma (OSCC) patients with pathologically positive LN. MATERIALS AND METHODS: In total, 47 OSCC patients with pathologically positive LN were retrospectively reviewed with preoperative 18F-FDG PET and CT/MRI. All patients underwent surgical resection, neck dissection and postoperative adjuvant radiotherapy and/or chemotherapy between March 2002 and October 2010. Histologic correlation was performed for findings of 18F-FDG PET and CT/MRI. RESULTS: Thirty-six (76.6%) of 47 cases were correctly diagnosed with neck LN metastasis by 18F-FDG PET and 32 (68.1%) of 47 cases were correctly diagnosed by CT/MRI. Follow-up ranged from 20 to 114 months (median, 56 months). Clinically negative nodal status evaluated by 18F-FDG PET or CT/MRI revealed a trend toward better clinical outcomes in terms of overall survival, disease-free survival, local recurrence-free survival, regional nodal recurrence-free survival, and distant metastasis-free survival rates even though the trends were not statistically significant. However, there was no impact of neck node standardized uptake value (SUVmax) on clinical outcomes. Notably, SUVmax showed significant correlation with tumor size in LN (p < 0.01, R2 = 0.62). PET and CT/MRI status of LN also had significant correlation with the size of intranodal tumor deposit (p < 0.05, R2 = 0.37 and p < 0.01, R2 = 0.48, respectively). CONCLUSION: 18F-FDG PET and CT/MRI at the neck LNs might improve risk stratification in OSCC patients with pathologically positive neck LN in this study, even without significant prognostic value of SUVmax.
Carcinoma, Squamous Cell
;
Disease-Free Survival
;
Electrons
;
Fluorodeoxyglucose F18
;
Follow-Up Studies
;
Humans
;
Lymph Nodes
;
Magnetic Resonance Imaging
;
Magnetic Resonance Spectroscopy
;
Magnetics
;
Magnets
;
Mouth
;
Neck
;
Neck Dissection
;
Neoplasm Metastasis
;
Positron-Emission Tomography
;
Radiotherapy, Adjuvant
;
Retrospective Studies
;
Survival Rate
;
Tomography, X-Ray Computed
6.Prevalence and Correlates of Depressive Symptoms among North Korean Defectors Living in South Korea for More than One Year.
Bong Hee JEON ; Moon Doo KIM ; Seong Chul HONG ; Na Ri KIM ; Chang In LEE ; Young Sook KWAK ; Joon Hyuk PARK ; Jaehwan CHUNG ; Hanul CHONG ; Eun Kyung JWA ; Min Ho BAE ; Sanghee KIM ; Bora YOO ; Jun Hwa LEE ; Mi Yeul HYUN ; Mi Jeong YANG ; Duk Soo KIM
Psychiatry Investigation 2009;6(3):122-130
OBJECTIVE: This study examined the prevalence and correlates of depressive symptoms in North Korean defectors who have been living in South Korea for more than one year. METHODS: We used questionnaires developed by the authors to collect sociodemographic data in addition to the Center for Epidemiologic Studies Depression Scale (CES-D), the Psychosocial Well-being Index to measure stress, and a social support scale. A total of 367 subjects were included in this study. RESULTS: The results showed that 30.5% of the men and 34.7% of the women reported depressive symptoms, and 33.1% of the men and 36.1% of the women exhibited signs of severe distress. Correlates of depressive symptoms were lack of occupation [odds ratio (OR)=2.198, 95% confidence interval (CI), 1.247-3.873], having escaped without family (OR=1.725, 95% CI, 1.006-2.959), and a poor subjective sense of health status (OR=3.111, 95% CI, 1.591-6.085). CONCLUSION: Continuing vocational training and career management, psychological support programs, and intensive physical health services are needed to improve the mental health of this population.
Depression
;
Epidemiologic Studies
;
Female
;
Health Services
;
Humans
;
Male
;
Mental Health
;
Occupations
;
Prevalence
;
Surveys and Questionnaires
;
Republic of Korea
;
United Nations
7.Experience with a Simulation Drill for Novel Influenza A (H1N1).
Dongsuk LEE ; Eun Suk PARK ; Mee Kweon OH ; Hyang Suk KIM ; Jeong Yeon PARK ; Shin Ok KOH ; Min Hong JWA ; In Cheol PARK ; Kyeong Ae KIM ; Kyeong Hwan OH ; Chang Oh KIM ; Sang Hun HAN ; Jun Yong CHOI ; June Myung KIM ; Ju Hyun LEE ; Eun Jin HA ; Dong Soo KIM ; Dongsik BANG ; Kyungwon LEE
Korean Journal of Nosocomial Infection Control 2010;15(2):103-111
BACKGROUND: It is important that hospitals conduct disaster drills to ensure prompt response in case of a pandemic and thereby prevent a biological disaster. METHODS: In a university hospital of Seoul, a drill was arranged by the members of the drill preparation team who were a part of the response team for infection control of novel influenza A (H1N1). The drill preparation team designed the scenario for the drill, made plans to resolve the potential problems that could occur during that scenario, and organized a survey team and a survey methodology. The scenario consisted of 2 modules: (1) for an intensive care unit and (2) for an emergency care center. The surveyors and field participants were evaluated after the drill exercise. RESULTS: This drill was conducted to improve the response to outbreaks of new infectious diseases. The drill event showed that the communication among the members responsible for the infection control was effective. However, the drill revealed certain drawbacks in the process; this drawbacks involved availability of adequate quarantine space, education on using personal protective equipments, assignment of medical and nonmedical staff, management of visitors, and installment of air-conditioners, heaters, and ventilation units in the areas with H1N1 outbreak. CONCLUSION: This drill helped to improve the process of infection control and overcome the drawbacks in the current process, and thereby helped in achieving positive outcome during the actual pandemic situation when the number of hospital visits and admissions because of H1N1 pandemic had rapidly increased. Although disaster plans and drills are not actively performed, the drill for infection control is essential because the risk for an outbreak of a new infectious disease is increasing.
Communicable Diseases
;
Surveys and Questionnaires
;
Dietary Sucrose
;
Disasters
;
Disease Outbreaks
;
Emergency Medical Services
;
Humans
;
Infection Control
;
Influenza, Human
;
Intensive Care Units
;
Mandrillus
;
Pandemics
;
Quarantine
;
Ventilation
8.Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study
Songji CHOI ; Seyoung SEO ; Ju Hyun LEE ; Koung Jin SUH ; Ji-Won KIM ; Jin Won KIM ; Se Hyun KIM ; Yu Jung KIM ; Keun-Wook LEE ; Jwa Hoon KIM ; Tae Won KIM ; Yong Sang HONG ; Sun Young KIM ; Jeong Eun KIM ; Sang-We KIM ; Dae Ho LEE ; Jae Cheol LEE ; Chang-Min CHOI ; Shinkyo YOON ; Su-Jin KOH ; Young Joo MIN ; Yongchel AHN ; Hwa Jung KIM ; Jin Ho BAEK ; Sook Ryun PARK ; Jee Hyun KIM
Cancer Research and Treatment 2024;56(2):404-413
Purpose:
The female sex is reported to have a higher risk of adverse events (AEs) from cytotoxic chemotherapy. Few studies examined the sex differences in AEs and their impact on the use of medical services during adjuvant chemotherapy. This sub-study aimed to compare the incidence of any grade and grade ≥ 3 AEs, healthcare utilization, chemotherapy completion rate, and dose intensity according to sex.
Materials and Methods:
This is a sub-study of a multicenter cohort conducted in Korea that evaluated the impact of healthcare reimbursement on AE evaluation in patients who received adjuvant chemotherapy between September 2013 and December 2016 at four hospitals in Korea.
Results:
A total of 1,170 patients with colorectal, gastric, or non–small cell lung cancer were included in the study. Female patients were younger, had fewer comorbidities, and experienced less postoperative weight loss of > 10%. Females had significantly higher rates of any grade AEs including nausea, abdominal pain, stomatitis, vomiting, and neutropenia, and experienced more grade ≥ 3 neutropenia, nausea, and vomiting. The dose intensity of chemotherapy was significantly lower in females, and they also experienced more frequent dose reduction after the first cycle. Moreover, female patients receiving platinum-containing regimens had significantly higher rates of unscheduled outpatient visits.
Conclusion
Our study found that females experienced a higher incidence of multiple any-grade AEs and severe neutropenia, nausea, and vomiting, across various cancer types, leading to more frequent dose reductions. Physicians should be aware of sex differences in AEs for chemotherapy decisions.